| Brazil
Renata Fialho de Oliveira has over 20 years’ experience working in the corporate and M&A area. She provides counsel to domestic and foreign clients on complex corporate, commercial, and international law issues, representing private equity firms, private acquirers and target companies in a variety of Brazilian and cross-border acquisitions, dispositions, spin-offs, restructurings and joint ventures.
In the area of mergers and acquisitions clients rely upon her advice across the full spectrum of issues, including advance preparation of prospective targets, stock sales and purchases, asset sales and purchases, strategic mergers, private equity, leveraged buyouts and joint ventures. She represents private equity and strategic investors in a wide variety of transactional matters.
Renata typically works for corporate clients, commonly multinational corporations, private equity funds and strategic investors (in many cases operational companies which are invested by private equity funds), as well for not-for-profit entities doing business in the healthcare sector.
Her clients include Clariant, Diaverum, Sociedade Beneficente Israelita Brasileiro Hospital Albert Einstein, Stratus, and InvestFarma.
Renata creates genuine bonds with her clients, which develop from her deep interest in their matters and concerns and intent to deliver results that best meet their needs.
“I am extremely technical, objective, collaborative, thoughtful, balanced with a proactive and creative attitude,” she commented. “I am a deal maker, not a deal breaker. Personality-wise, I usually help foster a pro-deal environment while safeguarding my clients’ interests.”
Some of Renata’s significant cases include:
• Sociedade Beneficente Israelita Brasileira’s acquisition of all the assets linked to the health centre of Hospital Órion, in Goiânia.
• Clariant’s acquisition of the remaining 70% of Brazilian personal care company Beraca it did not previously own
• Diaverum’s Acquisition of ACS Brasil Cirurgica
• Diaverum’s acquisition of CNTT – Clínica de Nefrologia e Transplantes do Tatuapé.
• Diaverum’s acquisition of INEDI – Instituto de Nefrologia e Diálise Ltda
• McQuade Center for Strategic Research and Development, LLC’s agreement with Aché Laboratórios Farmacêuticos S.A. (Aché) to co-develop a therapy with the potential to treat general anxiety disorder (GAD) and post-traumatic stress disorder (PTSD)
• InvestFarma’s acquisition of FarmaDelivery
• Stratus SCP Brasil Coinvestimento II – Fundo de Participações Multiestratégia’s acquisition 100% of Investfarma SA
• EBVentures acquisition of a minority interest in Labi Exames
Renata’s recent awards include:
• Chambers and Partners, Life Sciences, 2022
• Análise Advocacia Mulher 2022, Corporate and Contracts
• Who’s Who Legal, Life Sciences Legal Global Leader, 2022
• Análise Advocacia 500, Health Sector
• Who’s Who Legal, Life Sciences National Leader, 2021
• Client Choice Award Life Sciences Brazil, 2021
• Who’s Who Legal, Life Sciences Transactional, Global Leader 2021
• Who’s Who Legal, National Leader, 2020
• Who’s Who Legal, National Leader, 2019
• Legal 500, Corporate and M&A, 2018
